Sensorineural Hearing Loss in Postmeningitic Children

Otology and Neurotology

Volumn 24, Issue 6, 2003, Pages 907-912

  Wellman, Mark B ^a   Sommer, Doron D ^a   McKenna, Joseph ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bacterial meningitis; Pediatric; Sensorineural hearing loss

Indexed keywords

DEXAMETHASONE;

AUDIOLOGY; AUDIOMETRY; BACTERIAL MENINGITIS; CHILD; DISEASE ASSOCIATION; DISEASE DURATION; ELECTRIC ACTIVITY; FEMALE; HAEMOPHILUS INFLUENZAE; HEARING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

AGE DISTRIBUTION; AUDIOMETRY; CANADA; CHILD; CHILD, PRESCHOOL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 0242440355     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200311000-00015     Document Type: Review

References (45)

1. Dodge P, Davis H, Feigin R, et al. Prospective evaluation of hearing impairment as a sequelae of acute bacterial meningitis. N Engl J Med 1984;311:869-74.
2. Kulahi I, Ozturk M, Bilen C, et al. Evaluation of hearing loss with auditory brainstem responses in the early and late period of bacterial meningitis in children. J Laryngol Otol 1997;111:223-7.
3. Richardson M, Williamson T, Reid A, et al. Otoacoustic emissions as a screening test for hearing impairment in children recovering from acute bacterial meningitis. Pediatrics 1998;102:1364-8.
4. Ozdamar O, Kraus N, Stein L. Auditory brainstem responses in infants recovering from bacterial meningitis: audiologic evaluation. Arch Otolaryngol 1983;109:13-8.
5. Nadol J. Hearing loss as a sequalae of meningitis. Ann Otol Rhinol Laryngol 1978;88:397-9.
6. International Classification of Diseases. 9th rev. Clinical Modification (ICD-9-CM) Canadian Edition. Hamilton, Ontario: McMaster University, 2000.
7. Brackman D, Don M, Selters W. Electrical response audiometry. In Lee K, ed. Essential Otolaryngology Head and Neck Surgery. 7th ed. New Haven: Appleton & Lange, 1999:67-91.
8. Raghunathan M, Mehra YN. Electrical response audiometry (ERA) in infants. Indian J Pediatr 1992;59:601-7.
9. Stapells DR, Kurtzberg D. Evoked potential assessment of auditory system integrity in infants. Clin Perinatol 1991;18:497-518.
10. Yantis P. Pure tone air-conduction testing. In Katz J, ed. Handbook of Clinical Audiology. 3rd ed. Baltimore: Williams & Wilkins, 1985:164-78.
11. Paperella M, Sugiura S. The pathology of suppurative labyrinthitis. Ann Otol Rhinol Laryngol 1967;76:554-87.
12. Vienny H, Despland P, Lutschg J, et al. Early diagnosis and evolution of deafness in childhood bacterial meningitis: a study using auditory evoked potentials. Pediatrics 1984;73:579-86.
13. Dodds A, Tyszkiewicz E, Ramsden R. Cochlear implantation after bacterial meningitis: the dangers of delay. Arch Dis Child 1997;76:139-40.
14. Gibson W, Brown C, Everingham C, et al. Necessity of early diagnosis and assessment of postmeningitis children in view of cochlear implantation. Ann Otol Rhinol Laryngol 1995;104:208-10.
15. Gulya J. Temporal Bone Histology and Histopathology. In Canalis R, Lambert P, eds. The Ear: Comprehensive Otology. Philadelphia: Lippincott Williams & Wilkins, 2000:86-7.
16. Igarashi M, Siato R, Alford B, et al. Temporal bone findings in pneumococcal meningitis. Arch Otol 1974;99:79-83.
17. Nylen O, Rosenhall U. Hemophilus influenzae meningitis and hearing. Int J Pediatr Otorhinolaryngol 1979;1:97-101.
18. Wooley A, Kirk K, Neumann A. Risk factors for hearing loss from meningitis in children. Arch Otolaryngol Head Neck Surg 1999;125:509-14.
19. Zimmerman R. Pneumococcal conjugate vaccine for young children. Am Fam Phys 2001;63:1991-8.
20. Shinefield H, Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J 2000;19:394-7.
21. Kayhty H, Ahman H, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995;172:1273-8.
22. Ahman H, Kayhty H, Tamminen P, et al. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 1996;15:134-9.
23. Ahman H, Kayhty H, Lehtonen H, et al. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998;17:211-6.
24. Sigurdardottir S, Vidarsson G, Gudnason T, et al. Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid. Pediatr Infect Dis J 1997;16:667-74.
25. Lieu T, Ray G, Black SB, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000;283:1460-69.
26. Riordan A, Thompson A, Hodgson J. Children who are seen but not referred: hearing assessment after bacterial meningitis. Br J Audiol 1993;27:375-77.
27. Riordan A, Thompson A, Hogson J. Hearing assessment after meningitis and meningococcal disease. Arch Dis Child 1995;72:441-2.
28. Drake R, Dravitski J, Voss L. Hearing in children after meningococcal meningitis. J Pediatr Child Health 2000;36:240-2.
29. Fortnum H, Hull D. Is hearing assessed after bacterial meningitis? Arch Dis Child 1992;67:1112-4.
30. Fortnum H, Farnsworth A, Davis A. The feasibility of evoked otoacoustic emissions as an in-patient hearing check after meningitis. Br J Audiol 1993;27:227-31.
31. Richardson M, Reid A, Tarlow M, et al. Hearing loss during bacterial meningitis. Arch Dis Child 1997;76:134-8.
32. Yoshinago-Italo C, Sedney A, Coulter D, et al. Language of early-and later-identified children with hearing loss. Pediatrics 1998;102:1161-71.
33. Davis J, Elfenbein J, Schum R, et al. Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children. J Speech Hear Dis 1986;57:53-62.
34. Geers A, Moog J. Factors predictive of the development of literacy in profoundly hearing-impaired adolescents. Volta Rev 1989;91:69-86.
35. Quigley S, Thomure E. Some effects of a hearing impairment on school performance. Urbana, Ill: Institute of Research on Exceptional Children, University of Illinois, 1968.
36. Davis J. Performance of young hearing-impaired children on a test of basic concepts. J Speech Hear Res 1974;17:342-51.
37. Holt J. Stanford Achievement Test-8th edition: reading comprehension subgroup results. Am Ann Deaf 1993;138:172-5.
38. Robinshaw H. Early intervention for hearing impairment: differences in the timing of communicative and linguistic development. Br J Audiol 1995;27:315-34.
39. Apuzzo M, Yoshinaga-Itano C. Early identification of infants with significant hearing loss and the Minnesota Child Dev Inventory. Sem Hear 1995;16:124-37.
40. Moeller M. Early intervention of hearing loss in children. Presented at the Fourth International Symposium on Childhood Deafness, Kiawah Island, SC, October 9-13, 1996.
41. Odio C, Faingezicht I, Paris M. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
42. Lebel MH, Freij B, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis. N Engl J Med 1988;319:964-71.
43. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. JAMA 1997;278:925-31.
44. Syrogiannopoulos G, Lourida A, Theodoridou M. Dexamethasone therapy for bacterial meningitis in children: 2 versus 4-day regimen. J Infect Dis 1994;169:853-8.
45. Roos K. Acute bacterial meningitis. Semin Neurol 2000;20:293-306.